Next Stage with You

Subaru Motorsports USA Unveils All-New WRX Rally Car and Announces Driver Travis Pastrana's Return to the ARA Series for the 2024 Season

Retrieved on: 
Wednesday, August 2, 2023
Learning, ARA, USAC, Table, FIA, Head, Torque, Eye, American Rally Association, WRX, Carbon, Subaru, VSC, Kevlar, Forest, Subaru Motorsports USA, SADEV, Next Stage with You, Safety, Rail transport, T45

CAMDEN, N.J., Aug. 2, 2023 /PRNewswire/ -- Subaru Motorsports USA today reveals the all-new WRX rally car for competition in the Open 4WD class of the American Rally Association (ARA) Championship.

Key Points: 
  • CAMDEN, N.J., Aug. 2, 2023 /PRNewswire/ -- Subaru Motorsports USA today reveals the all-new WRX rally car for competition in the Open 4WD class of the American Rally Association (ARA) Championship.
  • The #180 team of driver Brandon Semenuk and co-driver Keaton Williams will pilot the car in its racing debut at Ojibwe Forests Rally on August 24-25.
  • It was also announced today that extreme sport legend Travis Pastrana will join in a second car in the 2024 ARA season.
  • Fans should look forward to this awesome new WRX rally car leading the way as Subaru Motorsports USA and Vermont SportsCar enter this new era.

MyyShop Makes Waves at SXSW with Social Commerce Empowerment Plans for Content Creators

Retrieved on: 
Friday, March 17, 2023
DHgate.com, Heart, Small business, Table, Austin Convention Center, Social commerce, MSME & Startups Forum - Bharat, Love, Next Stage with You, CIE, SXSW, Social media, Online shopping, Music

"We are thrilled with the positive responses we received at SXSW," said Diane Wang, founder, chairperson, and CEO of DHGATE Group.

Key Points: 
  • "We are thrilled with the positive responses we received at SXSW," said Diane Wang, founder, chairperson, and CEO of DHGATE Group.
  • MyyShop held a panel discussion themed Unlocking the Power of Social Commerce at the Next Stage of CIE on March 15, giving visitors an opportunity to learn how social commerce is transforming the retail landscape in America.
  • MyyShop panelists also shared, only in 2022, content creators made over $3.5 million from recommending their favorite DHgate products to shoppers on various social media platforms.
  • In the past two years, Myyshop has worked and built partnerships with global content creators with experience in social commerce, empowered creators through the Academy program, and hosted events to support their entrepreneurial dreams.

MyyShop Lands at SXSW 2023, Helping Creators Effortlessly Cash In on Social Commerce

Retrieved on: 
Friday, March 10, 2023
Austin Convention Center, Education, Social media, Micro, Culture, SXSW, Music, Social commerce, Woman, AI, Austin–Bergstrom International Airport, Health, Generation, Next Stage with You, MSME-Champions, Nightclub, Online shopping, Tourism, Small

Setting out to impress millions of SXSW attendees and travelers to the city, MyyShop appears on billboards at Austin International Airport and will be hosting a panel at Next Stage, SXSW, under the theme of Unlocking the Power of Social Commerce.

Key Points: 
  • Setting out to impress millions of SXSW attendees and travelers to the city, MyyShop appears on billboards at Austin International Airport and will be hosting a panel at Next Stage, SXSW, under the theme of Unlocking the Power of Social Commerce.
  • MyyShop will be at booth #1023 inside the Austin Convention Center, which hosts exhibitors from industries on the cutting edge of technology, design, social goods, health, wellness, and more.
  • With MyyShop, anyone can easily "Share to Earn" by selling through shoppable feeds or leveraging influencer marketing on social platforms.
  • We invite you to drop by our booth, attend our panel and see what tremendous opportunities MyyShop can offer you.

Summit Therapeutics to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022

Retrieved on: 
Thursday, October 13, 2022
Infection, Private Securities Litigation Reform Act, Food and Drug Administration Amendments Act of 2007, Susceptibility, NASDAQ, CDI, Pharmacist, Nasdaq, Treatment, Next Stage with You, Society of Infectious Diseases Pharmacists, Journal, Commensalism, Infectious Diseases Society of America, Vancomycin, Safety, Poster, Quality of life, Randomness, SMMT, Knowledge, Company, Marketing, Summit, PIDS, GLOBE, Clinical trial, The Journal of Infectious Diseases, Ridinilazole, Research, Security (finance), Giovanni, Trial of the century, U.S. Securities and Exchange Commission, IDSA, Diarrhea, Risk, Clostridioides difficile (bacteria), Patient, Clostridioides difficile infection, Coronavirus, Food, Efficacy, Society, Recurrence, COVID-19, Epidemiology, Pharmaceutical industry, Vaccine, Medical device, Clostridium, Clostridioides, DRS

Menlo Park, California, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) and its product candidate, ridinilazole, will have an oral podium presentation and a poster presentation at IDWeek 2022.

Key Points: 
  • Menlo Park, California, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) and its product candidate, ridinilazole, will have an oral podium presentation and a poster presentation at IDWeek 2022.
  • In the Ri-CoDIFy study, ridinilazole resulted in a meaningful reduction in the rate of recurrence of C. diff.
  • infection (8.1% vs 17.3%) and achieved a numerically higher sustained clinical response1 rate (73.0% vs 70.7%) than vancomycin.
  • We are pleased to inform that the results of our clinical study validated the assertions of Drs.